Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Details for Australian Patent Application No. 2003232034 (hide)

Event Publications

28 August 2003 Complete Application Filed

Priority application(s): 60/377,321 02.05.02 US; 60/378,730 08.05.02 US; 60/383,075 24.05.02 US; 60/384,044 29.05.02 US; 60/384,327 30.05.02 US; 60/384,215 30.05.02 US; 60/384,297 30.05.02 US; 60/384,296 30.05.02 US; 60/384,352 30.05.02 US; 60/385,211 31.05.02 US; 60/393,333 02.07.02 US; 60/402,154 09.08.02 US; 60/402,205 09.08.02 US; 60/402,204 09.08.02 US; 60/402,171 09.08.02 US; 60/405,175 22.08.02 US; 60/406,129 27.08.02 US; 60/412,954 23.09.02 US; 60/414,975 30.09.02 US; 60/416,661 07.10.02 US; 60/420,851 24.10.02 US; 60/422,547 31.10.02 US; 10/

8 January 2004 Application Open to Public Inspection

Published as AU-A-2003232034

14 September 2006 Amendment Made

The nature of the amendment is: Amend co-inventor name from MaCdougall, John R. to MacDougall, John R.

27 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.